GlassScriptPhysician profile
Geetha Pillai
NPI 1356335301
$5,665.97
in general payments reported to CMS, 2019-2025
34 companies · $2,124 in 2025
The $2,124 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.29 · 2020: $50.49 · 2021: $14.83 · 2022: $34.17 · 2023: $1,800 · 2024: $1,554 · 2025: $2,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,745 · Travel and Lodging: $640 · Education: $92.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,745.06 |
| Travel and Lodging | $640.40 |
| Education | $92.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,152.46 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $694.81 | 2023-2025 | |
| Stryker Corporation | $640.40 | 2023 | Blueprint Patient Specific Instrumentation |
| Pfizer INC. | $391.82 | 2023-2025 | |
| Amgen INC. | $388.19 | 2023-2025 | Otezla, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $291.43 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $285.98 | 2023-2025 | Veozah |
| Lilly USA, LLC | $249.21 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Noah Medical Corporation | $241.69 | 2025 | Galaxy |
| Otsuka America Pharmaceutical, INC. | $145.13 | 2024-2025 | Rexulti |
| Abbott Laboratories | $125.14 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Supernus Pharmaceuticals, INC. | $118.76 | 2019-2025 | Qelbree, Qelbree |
| Exact Sciences Corporation | $118.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $108.29 | 2023-2025 | Arexvy, Shingrix |
| Medtronic, INC. | $95.28 | 2024-2025 | Symplicity G3, Minimed 780g |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $71.14 | 2023-2025 | Injectafer |
| Vanda Pharmaceuticals INC. | $50.89 | 2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $48.82 | 2025 | Caplyta |
| Merck Sharp & Dohme LLC | $45.78 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.65 | 2023 | Jardiance, Tradjenta |
| Dexcom, INC. | $39.81 | 2025 | Dexcom G6 Transmitter |
| Lundbeck LLC | $38.47 | 2025 | Rexulti |
| Globus Medical, INC. | $33.71 | 2025 | Senza |
| Idorsia Pharmaceuticals US INC | $32.96 | 2022-2023 | Quviviq |
| Recor Medical INC | $32.64 | 2025 | Paradise Ultrasound Renal Denervation System |
| Amarin Pharma, INC. | $30.71 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.47 | 2025 | |
| Genentech USA, INC. | $23.17 | 2019 | |
| Dynavax Technologies Corporation | $22.41 | 2023 | Heplisav-B |
| Baxter Healthcare | $18.26 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $17.75 | 2020 | |
| Endo Pharmaceuticals INC. | $16.33 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.82 | 2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $12.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geetha Pillai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.